Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts. 2007

Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
Laboratory of Pharmacology, College of Pharmacy and Research Institute for Drug Development, Pusan National University, San 30, Jang-Jun-dong, Geum-Jung-gu, Busan 609-735, Republic of Korea.

Phosphatidic acid (PA) increased intracellular Ca(2+) concentration ([Ca(2+)](i)) in C6 rat glioma and L2071 mouse fibroblast cells. Dioleoyl PA (PA, 18:1) was the most efficacious, followed by dipalmitoyl PA (16:0 PA) and dimyristoyl PA (14:0 PA). Lysophosphatidic acid (LPA) also increased the [Ca(2+)](i) in the both cells. PA desensitized LPA-induced Ca(2+) response completely in C6 cells, but partly in L2071 cells. Treatment of pertussis toxin (PTX), a specific inhibitor of G(i/o)-type G proteins, completely ameliorated LPA- and PA-induced Ca(2+) response in C6 cells. However, in L2071 cells, PTX inhibited PA-induced Ca(2+) increase by 80% and LPA-induced one by 20%. Ki16425, a specific inhibitor of LPA(1)/LPA(3) receptors, completely inhibited both LPA- and PA-induced Ca(2+) responses in C6 cells. On the other hand, in L2071 cells, Ki16425 completely inhibited PA-induced Ca(2+) response, but partly LPA-induced one. VPC32183, another specific inhibitor of LPA(1)/LPA(3) receptors, completely inhibited LPA- and PA-induced Ca(2+) responses in both C6 and L2071 cells. Therefore, PA and LPA appear to increase [Ca(2+)](i) through Ki16425/VPC32183-sensitive LPA receptor coupled to PTX-sensitive G proteins in C6 cells. In L2071 cells, however, LPA increases [Ca(2+)](i) through Ki16425-insensitive LPA receptor coupled to PTX-insensitive G proteins and Ki16425-sensitive LPA receptor coupled to PTX-sensitive G protein, whereas PA utilized only the latter pathway. Our results suggest that PA acts as a partial agonist on endogenous LPA receptors, which are sensitive to Ki16425 and coupled to PTX-sensitive G protein, but not on LPA receptors, which are not sensitive to Ki16425 and coupled to PTX-insensitive G protein.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008246 Lysophospholipids Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal. Lysophosphatidic Acids,Lysophospholipid,Acids, Lysophosphatidic
D010712 Phosphatidic Acids Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups. Ammonium Phosphatidate,Diacylglycerophosphates,Phosphatidic Acid,Acid, Phosphatidic,Acids, Phosphatidic,Phosphatidate, Ammonium
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
August 1996, The American journal of physiology,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
May 1998, The Journal of biological chemistry,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
January 2002, Physiological research,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
January 1993, Neuroendocrinology,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
June 2007, Neurochemical research,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
February 1983, The Journal of biological chemistry,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
May 2015, Biochemical and biophysical research communications,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
August 1996, Journal of neurochemistry,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
October 1998, Journal of neurochemistry,
Young-Ja Chang, and Yu-Lee Kim, and Yun-Kyung Lee, and Santosh J Sacket, and Kyeok Kim, and Hyo-Lim Kim, and Mijin Han, and Yoe-Sik Bae, and Fumikazu Okajima, and Dong-Soon Im
January 1983, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!